CMColleen M. Makey

Colleen M. Makey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Colleen M. Makey has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Thomas F. Webster

    Boston University School of Public Health , Department of Environmental Health, 715 Albany Street T4W, Boston, Massachusetts 02118, United States

    4 shared publications
  • Andreas Sjödin

    Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA

    3 shared publications
  • Janice Weinberg

    School of Public Health, Boston University, Boston, USA

    3 shared publications
  • Michael D. McClean

    Department of Environmental Health, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA

    3 shared publications
  • Elizabeth N. Pearce

    Section of Endocrinology, Diabetes, and Nutrition, Boston University School of Medicine, 72 E. Concord Street, Boston, MA 02118, USA

    2 shared publications
  • Lewis E. Braverman

    Section of Endocrinology, Diabetes, and Nutrition, Boston University School of Medicine, 72 E. Concord Street, Boston, MA 02118, USA

    2 shared publications

Latest Publications

  • Airborne Precursors Predict Maternal Serum Perfluoroalkyl Acid Concentrations

    by Colleen M. Makey, Thomas F. Webster, Jonathan W. Martin, Mahiba Shoeib, Tom Harner, Linda Dix-Cooper, Glenys M. Webster

    Human exposure to persistent perfluoroalkyl acids (PFAAs), including perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), and perfluorooctanesulfonate (PFOS), can occur directly from contaminated food, water, air, and dust. However, precursors to PFAAs (PreFAAs), such as dipolyfluoroalkyl phosphates (diPAPs), fluorotelomer alcohols (FTOHs), perfluorooctyl sulfonamides (FOSAs), and sulfonamidoethanols (FOSEs), which can be biotransformed to PFAAs, may also be a source of exposure. PFAAs were analyzed in 50 maternal sera samples collected in 2007–2008 from participants in Vancouver, Canada, while PFAAs and PreFAAs were measured in matching samples of residential bedroom air collected by passive sampler and in sieved vacuum dust (<150 μm). Concentrations of PreFAAs were higher than for PFAAs in air and dust. Positive associations were discovered between airborne 10:2 FTOH and serum PFOA and PFNA and between airborne MeFOSE and serum PFOS. On average, serum PFOS concentrations were 2.3 ng/mL (95%CI: 0.40, 4.3) higher in participants with airborne MeFOSE concentrations in the highest tertile relative to the lowest tertile. Among all PFAAs, only PFNA in air and vacuum dust predicted serum PFNA. Results suggest that airborne PFAA precursors were a source of PFOA, PFNA, and PFOS exposure in this population.


  • Polybrominated diphenyl ether exposure and reproductive hormones in North American men

    by Colleen M. Makey, Michael D. McClean, Lewis E. Braverman, Elizabeth N. Pearce, Andreas Sjödin, Janice Weinberg, Thomas F. Webster


  • Open Access

    Polybrominated Diphenyl Ether Exposure and Thyroid Function Tests in North American Adults

    by Colleen M. Makey, Michael D. McClean, Lewis E. Braverman, Elizabeth N. Pearce, Xue-Mei He, Andreas Sjödin, Janice M. Weinberg, Thomas F. Webster

    Background: Polybrominated diphenyl ethers (PBDEs) are flame-retardant chemicals that are added to many consumer products. Multiple animal studies have shown PBDEs to be thyroid hormone (TH) disruptors. Epidemiologic evidence of PBDE exposure associated with TH disruption has been inconclusive. Objectives: We used repeated measures to estimate associations between serum PBDE concentrations and THs in a North American adult cohort. Methods: From 2010 to 2011, we collected ≤ 3 serum samples at approximately 6-month intervals from 52 healthy adult office workers from Boston, Massachusetts, for analysis of PBDE congeners and THs. Results: The geometric mean sum concentrations of the most prevalent PBDE congeners (BDE-28, BDE-47, BDE-99, BDE-100, and BDE-153) were 22 ng/g lipid in winter 2010, 23 ng/g lipid in summer 2010, and 19 ng/g lipid in winter 2011. BDE-47 was the predominant congener. Based on a multivariable mixed regression model, we estimated that on average, a 1-ng/g serum increase in BDE-47 was associated with a 2.6-μg/dL decrease in total thyroxine (T4) (95% CI: –4.7, –0.35). Total T4 was inversely associated with each PBDE congener. Serum concentrations of PBDEs were not strongly associated with total triiodothyronine (T3), free T4, or thyroid-stimulating hormone (TSH). Conclusion: These results are consistent with those from animal studies showing that exposure to PBDEs is associated with a decrease in serum T4. Because the other TH concentrations did not appear to be associated with BDE exposures, our findings do not indicate effects on the pituitary–thyroid axis. Taken together, our findings suggest that PBDE exposure might decrease the binding of T4 to serum T4 binding proteins. Citation: Makey CM, McClean MD, Braverman LE, Pearce EN, He XM, Sjödin A, Weinberg JM, Webster TF. 2016. Polybrominated diphenyl ether exposure and thyroid function tests in North American adults. Environ Health Perspect 124:420–425; http://dx.doi.org/10.1289/ehp.1509755


  • Open Access

    Temporal Variability of Polybrominated Diphenyl Ether (PBDE) Serum Concentrations over One Year

    by Colleen M. Makey, Michael D. McClean, Andreas Sjödin, Janice Weinberg, Courtney C. Carignan, Thomas F. Webster

    Polybrominated diphenyl ethers (PBDEs) are flame retardant chemicals used in consumer products. They are common contaminants in human serum and associated with adverse health effects. Our objectives were to characterize PBDE serum concentrations in a New England cohort and assess temporal variability of this exposure biomarker over a one-year period. We collected three repeated measurements at six-month intervals from 52 office workers from the greater Boston (MA, United States) area from 2010 to 2011. The intraclass correlation coefficient for BDEs 28, 47, 99, 100, and 153 ranged from 0.87 to 0.99, indicating that a single serum measurement can reliably estimate exposure over a one-year period. This was true for both lipid adjusted and nonlipid adjusted concentrations. The kappa statistics, quantifying the level of agreement of categorical exposure classification, based on medians, tertiles, or quartiles ranged from 0.67 to 0.90. Some congeners showed nonsignificant increases from sampling round 1 (winter) to round 2 (summer) and significant decreases from round 2 to round 3 (winter). This study highlights the high reliability of a single serum PBDE measurement for use in human epidemiologic studies.


  • Open Access

    Disclosure of Hydraulic Fracturing Fluid Chemical Additives: Analysis of Regulations

    by Alexis L. Maule, Colleen M. Makey, Eugene B. Benson, Isaac J. Burrows, Madeleine K. Scammell

    Hydraulic fracturing is used to extract natural gas from shale formations. The process involves injecting into the ground fracturing fluids that contain thousands of gallons of chemical additives. Companies are not mandated by federal regulations to disclose the identities or quantities of chemicals used during hydraulic fracturing operations on private or public lands. States have begun to regulate hydraulic fracturing fluids by mandating chemical disclosure. These laws have shortcomings including nondisclosure of proprietary or “trade secret” mixtures, insufficient penalties for reporting inaccurate or incomplete information, and timelines that allow for after-the-fact reporting. These limitations leave lawmakers, regulators, public safety officers, and the public uninformed and ill-prepared to anticipate and respond to possible environmental and human health hazards associated with hydraulic fracturing fluids. We explore hydraulic fracturing exemptions from federal regulations, as well as current and future efforts to mandate chemical disclosure at the federal and state level.